Beryl Drugs Ltd.
BSE: 524606 | Sector: Health care |
NSE: N.A. | ISIN Code: INE415H01017 |
BSE 15:16 | 27 Jun | 8.48 |
0.16 (1.92%) |
OPEN
8.70 |
HIGH
8.70 |
LOW
8.48 |
NSE 05:30 | 01 Jan | Beryl Drugs Ltd |
OPEN | 8.70 |
PREVIOUS CLOSE | 8.32 |
VOLUME | 916 |
52-Week high | 19.30 |
52-Week low | 7.50 |
P/E | |
Mkt Cap.(Rs cr) | 4 |
Buy Price | 8.05 |
Buy Qty | 500.00 |
Sell Price | 8.48 |
Sell Qty | 147.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Beryl Drugs Ltd. (BERYLDRUGS) - Half Yearly Result
Particulars (![]() |
Mar '22 | Sep '21 | Mar '21 | Sep '20 | Mar '20 |
Net Sales/Income From Operations | 6.74 | 8.03 | 7.77 | 6.51 | 5.47 |
Other Income | 0.00 | 0.00 | 0.45 | 0.00 | 0.00 |
Total Income | 6.74 | 8.03 | 8.22 | 6.51 | 5.47 |
Total Expenditure | 6.78 | 7.41 | 7.36 | 5.28 | 5.28 |
Operating Profit | -0.04 | 0.62 | 0.86 | 1.22 | 0.19 |
Interest | 0.21 | 0.22 | 0.23 | 0.23 | 0.20 |
Gross Profit | -0.26 | 0.39 | 0.63 | 0.99 | -0.01 |
Depreciation | 0.54 | 0.54 | 0.58 | 0.69 | 0.45 |
PBT | -0.80 | -0.15 | 0.05 | 0.30 | -0.46 |
Tax | 0.01 | 0.00 | -0.05 | 0.05 | -0.17 |
Net Profit/(Loss) | -0.58 | -0.08 | -0.05 | 0.29 | -0.47 |
Minority Interest After NP | - | - | - | - | - |
Net Profit after Minority Interest | - | - | - | - | - |
Exceptional Items | 0.00 | 0.00 | 0.45 | 0.00 | 0.00 |
Profit After Exceptional Items | -0.58 | -0.08 | -0.50 | 0.29 | -0.47 |
Equity Share Capital | 5.07 | 5.07 | 5.07 | 5.07 | 5.07 |
Reserves Excluding Revaluation Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EPS | |||||
Basic EPS | 0.00 | -0.16 | 0.00 | 0.58 | 0.00 |
Public Share Holding | |||||
No Of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
Share Holding (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Promoters and Promoter Group Shareholding | |||||
a) Pledged/Encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
- Per. of Shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
- Per. of Shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
b) Non-encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
- Per. of shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
- Per. of shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Note : | PBT include deferred tax and fringe benefit tax Net profit figures include extra-ordinary items income/expenditure. |
Quick Links for Beryl Drugs:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices